Elizabeth Ann Winzeler is a Professor in the Department of Pediatrics at the University of California, San Diego, School of Medicine. She obtained her Ph.D. in 1996 and performed postdoctoral work at Stanford University Medical School before moving to a joint position at the Scripps Research Institute and the Genomics Institute of the Novartis Research Foundation (GNF). At GNF she led a malaria drug discovery program that discovered several novel antimalarial chemotypes that have since progressed into human trials. Since 2012 she has worked at University of California, San Diego where she leads a group that uses systematic, data intensive methods to solve problems at the interface of host pathogen biology, drug discovery and genomics. She is particularly interested in developing new therapeutic approaches that may be used in malaria eradication and elimination.
More info at: http://winzeler.ucsd.edu/